B-lactamase inhibitor picoline salt
View Patent ↗Provided herein are intermediates useful in the synthesis of β-lactamase inhibitors, and methods of making said intermediates and β-lactamase inhibitors.
1. A compound of Formula (II):
2. The compound of claim 1 in crystalline form.
3. The compound of claim 2 , characterized by an X-ray powder diffraction pattern substantially in accordance with pattern A, B, or C of FIG. 1A .
4. The compound of claim 2 , characterized by an X-ray powder diffraction pattern comprising characteristic peaks expressed in degrees 2θ (±0.2) at 10.48, 16.75, 18.27, 20.40, and 28.80.
5. The compound of claim 2 , characterized by an X-ray powder diffraction pattern comprising characteristic peaks expressed in degrees 2θ (±0.2) at 10.48, 11.69, 12.00, 12.81, 14.28, 15.69, 16.75, 17.50, 17.70, 18.27, 19.58, 20.40, 21.24, 21.85, 22.48, 23.55, 24.02, 24.26, 25.39, 26.8, 27.33, 28.80, 31.21, 31.67, 32.19, 32.63, 33.89, 35.73, 35.96, 36.30, and 37.82.
6. The compound of claim 2 , characterized by an X-ray powder diffraction pattern comprising characteristic peaks express in degrees 2θ (±0.2) at 10.48, 11.69, 12.00, 12.81, 14.28, 15.19, 15.69, 16.19, 16.75, 17.50, 17.70, 18.27, 19.58, 20.40, 20.79, 21.24, 21.85, 22.48, 23.55, 24.02, 24.26, 25.39, 25.66, 26.69, 26.82, 27.33, 28.19, 28.80, 29.16, 29.38, 29.82, 30.46, 31.21, 31.67, 32.19, 32.63, 33.40, 33.89, 34.25, 35.39, 35.73, 35.96, 36.30, 37.82, 38.72, and 38.83.
7. The compound of claim 2 , characterized by a differential scanning calorimetry thermogram having an endotherm peak at 139.94° C.±10° C.
8. The compound of claim 2 characterized by a differential scanning calorimetry thermogram having an exotherm peak at 181.77° C.±10° C.
9. The compound of claim 2 , characterized by a thermogravimetry curve having an onset temperature of 176.07±10° C.
10. The compound of claim 2 , further characterized by a thermo gravimetric analysis indicating a weight loss of 0-6% upon heating from 30±10° C. to 150±10° C.
11. A method for preparing the compound of Formula (II):
the method comprising the step of reacting a compound of Formula (I)
with a 2-picoline/sulfur trioxide complex in a solvent to form the compound of Formula (II).
12. The method of claim 11 , wherein the solvent comprises dichloromethane.
13. The method of claim 11 , further comprising the step of isolating the compound of Formula (II).
14. The method of claim 13 , wherein the step of isolating the compound of Formula (II) comprises crystalizing the compound of Formula (II).
15. The method of claim 11 , wherein the compound of Formula (II) is crystalline.
16. A crystalline piccoline salt of a compound of Formula (I)
characterized by an X-ray powder diffraction pattern comprising characteristic peaks expressed in degrees 2θ (±0.2) at 10.5, 16.8, 18.3, 20.4, and 28.8.
17. The compound of claim 16 , characterized by an X-ray powder diffraction pattern comprising characteristic peaks expressed in degrees 2θ (±0.2) at 10.48, 11.69, 12.00, 12.81, 14.28, 15.69, 16.75, 17.50, 17.70, 18.27, 19.58, 20.40, 21.24, 21.85, 22.48, 23.55, 24.02, 24.26, 25.39, 26.8, 27.33, 28.80, 31.21, 31.67, 32.19, 32.63, 33.89, 35.73, 35.96, 36.30, and 37.82.
18. The compound of claim 16 , characterized by a differential scanning calorimetry thermogram having an endotherm peak at 139.94° C.±10° C.
19. The compound of claim 16 , characterized by a differential scanning calorimetry thermogram having an exotherm peak at 181.77° C.±10° C.
20. The compound of claim 16 , characterized by a thermogravimetry curve having an onset temperature of 176.07±10° C.
21. The compound of claim 16 , further characterized by a thermo gravimetric analysis indicating a weight loss of 0-6% upon heating from 30±10° C. to 150±10° C.
22. The compound of claim 16 , obtained by a process comprising the step of reacting a compound of Formula (I)
with a 2-picoline/sulfur trioxide complex in a solvent to form the compound of Formula (II).